This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by George, J Articles by Shoenfeld, Y Search for Related Content PubMed PubMed Citation Articles by George, J Articles by Shoenfeld, Y Social Bookmarking                         What's this?

ß2 glycoprotein I containing immune-complexes in lupus patients: association with thrombocytopenia and lipoprotein (a) levels

B Gilburd

Department of Medicine B', Tel Aviv University, Israel

P Langevitz

The Rheumatology Unit, Tel Aviv University, Israel

Y Levy

Department of Medicine B', Tel Aviv University, Israel

R Nezlin

Department of Immunology, Weizmann Institute of Science, Rehovot, Israel

D Harats

Institute of Lipid and Atherosclerosis Research, Sheba Medical Center, Tel Hashomer, Sackler Faculty of Medicine, Tel Aviv University, Israel

Y Shoenfeld

Department of Medicine B', Tel Aviv University, Israel; Department of Medicine B', Sheba Medical Center, Tel-Hashomer 52621, Israel

In this study we determined the prevalence and clinical associations of immune-complexescontaining beta-2-glycoprotein I (b₂GPI) in randomly selected SLE patients.

We studied 38 consecutive SLE patients attending the Rheumatology Unit. Previous arterial or venous-thrombosis were documented by the appropriate diagnostic test. Lipid profile including total cholesterol, LDL, VLDL, HDL and Lp(a) levels were determined from the sera of the fasting patients. Antibodies to cardiolipin, oxidized LDL and b₂GPI were detected employing ELISA. b2GPI containing IgG immune-complexes were assayed by using a dot-blot assay.

Fourteen SLE patients (36.8%) were found to be positive for the presence of IgG anti-b₂GPI antibodies. Ten of the SLE patients (26.3%) were found to have high levels of b₂GPI containing immune-complexes. There was a positive correlation between b₂GPI-IC levels and the occurrence of thrombocytopenia in the patients (P < 0.05). Furthermore, patients with SLE and venous thrombosis had higher levels of b₂GPI-IC when compared with thrombosis-free patients or with healthy controls (P < 0.05). Patients with higher Lp(a) levels (> 50 mg/dl) possessed higher levels of b₂GPI-IC as compared with patients with lower Lp(a) concentration (< 20 mg/dl) (P < 0.05).

These results suggest that IC-containing b₂GPI can help in defining a subpopulation of SLE patients with increased risk of thrombocytopenia and further aid in resolving mechanisms of immune-mediated tissue damage.

Key Words: APS • ß2GPI • autoimunity • Lp(a) • immune-complex • SLE

Lupus, Vol. 8, No. 2, 116-120 (1999)
DOI: 10.1191/096120399678847470


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				A Voss, S Jacobsen, and N H. Heegaard Association of b2-glycoprotein I IgG and IgM antibodies with thrombosis and thrombocytopenia Lupus, August 1, 2001; 10(8): 533 - 538. [Abstract] [PDF]

				J G Hanly and S A Smith Autoimmune antiphospholipid antibodies and cryoglobulinemia Lupus, May 1, 2000; 9(4): 264 - 270. [Abstract] [PDF]

				A. Wierzbicki Lipids, cardiovascular disease and atherosclerosis in systemic lupus erythematosus Lupus, March 1, 2000; 9(3): 194 - 201. [Abstract] [PDF]

				J George, A Afek, B Gilburd, D Harats, and Y Shoenfeld Autoimmunity in atherosclerosis: lessons from experimental models Lupus, March 1, 2000; 9(3): 223 - 227. [Abstract] [PDF]